Navigation Links
Nosey Camera Could Bring Relief to 4 Million Brits
Date:10/31/2011

LONDON, October 31, 2011 /PRNewswire/ --

New tools build upon company's minimally-invasive Balloon Sinuplasty™ Platform to improve visualisation capabilities during sinus surgery for the treatment of chronic rhinosinusitis.

Millions of patients in the UK who suffer from nasal and sinus problems could be brought relief by two innovative technologies to help clear nasal blockages.

Sinusitis is the most common sinus related illness in the UK, with around nine million sufferers and is caused when the delicate membranes in the sinus become inflamed, causing a blockage.

The symptoms of sinusitis can include: pressure headaches, facial pain, nasal obstruction, toothache and fatigue.

Two new technologies, the Acclarent Cyclops™ Multi-Angle Endoscope and the Relieva Luma Sentry™ Sinus Illumination System, allow surgeons to navigate the sinus with an exceptional field of vision to check for any blockages or potential problems.

The sinuses are the air spaces behind the bones of the upper face, between the eyes and behind the forehead, nose and cheeks. The sinuses are narrow and tortuous anatomy, and even relatively minor inflammation can present a major obstacle.

Acclarent Cyclops™ Multi-Angle Endoscope and the Relieva Luma Sentry™ Sinus Illumination System allows the surgeon to directly visualise the natural opening of the sinuses, even parts which are just a few millimeters wide, and examine many angles with one scope.

The two innovations were developed by Acclarent, Inc. who also introduced Balloon Sinuplasty™, a technique in which a tiny balloon is guided into the sinuses to help clear blockages in the sinus in an effective manner.

The treatment has been hugely successful and since Balloon Sinuplasty was launched in 2005, more than 120,000 patients have been treated with the medical procedure.

For further information please visit http://www.balloonsinuplasty.co.uk

For more information on chronic sinusitis treatment visit: http://www.balloonsinuplasty.co.uk/sinusitis-facts/chronic-sinusitis-treatment-options/ and for information on sinus surgery visit: http://www.balloonsinuplasty.co.uk/sinusitis-facts/sinus-surgery/

About the Balloon Sinuplasty™ System: Since 2005, more than 120,000 patients have been treated with Balloon Sinuplasty technology in operating rooms and office settings. Acclarent's comprehensive visualisation capabilities enable surgeons to confidently access, dilate and irrigate targeted sinuses throughout every aspect of Endoscopic Sinus Surgery (ESS) with Balloon Sinuplasty technology and provide their patients with minimally invasive options that have been repeatedly proven safe and effective worldwide.

Acclarent, Inc.

Acclarent is a global medical technology company dedicated to the development of innovative products to further meet the needs of ENT surgeons and their patients. Based in Menlo Park, Calif., the company operates as a business unit of Ethicon, Inc., a Johnson & Johnson company.  Through its core technologies and commitment to innovation, Acclarent will continue to advance novel technologies in all areas of ENT. Acclarent markets and sells its products worldwide and its technology has been used by thousands of physicians. For more information about Acclarent, visit http://www.Acclarent.com.


'/>"/>
SOURCE Balloon Sinuplasty(TM)
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Medigus and Tower Semiconductor Announce Worlds Smallest Medical Video Camera Based on Advanced CMOS Image Sensor
2. MEDX Installs Two Next Generation T-Quest™ Compact Gamma Cameras
3. Visionsense Corp Announces 500 Patients Milestone With Neurosurgical 3D Camera at Emory University Hospital in Atlanta, GA
4. American Heart Association Comment Saving Lives in Type 2 Diabetics: Could It Be as Easy as Lowering Blood Pressure?
5. Feeling Anxious or Distracted? New Research Shows a Cup of Tea Could Help
6. New Data Show That GlaxoSmithKlines Rotarix(R) Could Be Given With Other Routine Infant Vaccines in the U.S.
7. Mayo Clinic Study Shows Drug Could Effectively Treat, Prevent the Spread of Breast Cancer
8. St. Jude Finds Molecule That Could Improve Cancer Vaccine and Therapy for Other Diseases
9. Independent Physician Surveys Show if Approved, MF101 Could Become First-Line Treatment for Menopause Symptoms
10. Recent Data Study Suggests Cortisol Could Help Alleviate Suffering for Those With Chronic Fatigue Syndrome and Fibromyalgia
11. Molecular Science Could Further Improve Leukemia Survival, Say St. Jude Researchers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... January 18, 2017 , , Marks E-QURE ... distribution agreement, following similar agreements in Israel ... Wound care is $2 5 billion ... E-QURE Corp. (OTCQB: EQUR), a leader in medical devices for the treatment of ... Médica Equipos Médicos S.A.S. (TeckMedica) in Colombia for the ...
(Date:1/19/2017)... , Jan. 18, 2017 The drug ... billion by 2021 from USD 1,179.20 billion in 2016, ... Increasing prevalence of chronic diseases, increasing demand for ... factors driving the growth of this market. Whereas, self-administration ... generic drugs offer significant growth opportunities for players operating ...
(Date:1/18/2017)... and PUNE, India , January 18, 2017 ... Market Research, titled, "Breast Imaging Technologies Market by Type: Global ... breast imaging technologies market size was valued at $2,544 million ... 2022, growing at a CAGR of 8.4% from 2016 to ... Europe together accounted for over three-fourths market share ...
Breaking Medicine Technology:
(Date:1/20/2017)... ... ... “Knowledge is God’s Lighthouse”: a moving and colorful collection of prayers that ... of published author, Gene Gaapf, a retired truck driver, and a long-time writer, whose ... since high school and have many different titles,” Gaapf mentions about his different works. ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... an On-demand E-learning system for Clinical and Regulatory education for Physicians, Physician ... on Aerolib`s successful education methodology of Disease Specific Documentation Improvement. , The ...
(Date:1/19/2017)... ... , ... This month, the CEO and Clinical Director of Sober Living Outpatient, ... in Delray Beach, Florida has been changed from Sober Living Outpatient to ‘SLO Recovery ... Hoffman and Chris Farley are dying from heroin overdoses, but thousands of unnamed kids ...
(Date:1/19/2017)... CA (PRWEB) , ... January 19, 2017 , ... Cosmetic ... of plastic surgery procedures in order to make it easier for their readers to ... of the body they impact as well as the techniques used on those particular ...
(Date:1/19/2017)... ... January 19, 2017 , ... MB Business ... new $11,250,000 senior credit facility to Sunrise, Florida-based Management Health Systems, LLC, dba ... to facilitate a recapitalization of MedPro led by Harren Equity Partners. Brightwood ...
Breaking Medicine News(10 mins):